Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Apr;39(4):215-22.
doi: 10.1002/clc.22511. Epub 2016 Feb 5.

Implications of the New US Cholesterol Guidelines in the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil)

Marcio Sommer Bittencourt  1 , Henrique Lane Staniak  1 , Alexandre Costa Pereira  1   2 , Itamar S Santos  1   3 , Bruce B Duncan  4 , Raul D Santos  1 , Michael J Blaha  5 , Steve R Jones  5 , Peter P Toth  5   6   7 , Isabela M Bensenor  1   3 , Paulo A Lotufo  1   3
Affiliations

Implications of the New US Cholesterol Guidelines in the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil)

Marcio Sommer Bittencourt et al. Clin Cardiol. 2016 Apr.

Abstract

Background: The new US guidelines for the primary prevention of cardiovascular disease have substantially changed the approach to hyperlipidemia treatment. However, the impact of those recommendations in other populations is limited. In the present study, we evaluated the potential implications of those recommendations in the Brazilian population.

Hypothesis: The new U.S. recommendations may increase the proportion of individuals who are candidates for statin therapy.

Methods: We included all participants of the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil) without known cardiovascular disease. We calculated the indication for statin therapy according to the current Brazilian recommendations and the new US guidelines, using both the 5.0% and the 7.5% risk cutoffs to recommend treatment, and compared their impact in the Brazilian population stratified by age, sex, and race.

Results: Although the current guidelines would recommend treatment for 5499 (39.1%) individuals, the number of individuals eligible for statin therapy increased to 6014 (42.7%) and to 7130 (50.7%) using the 7.5% and 5% cutoffs, respectively (P < 0.001). This difference is more pronounced for older individuals, and virtually all individuals age >70 years would be eligible for statins, whereas the new guidelines would reduce the number of candidates for statin therapy in individuals age <45 years.

Conclusions: The application of the new US guidelines for the use of lipid-lowering medications in a large middle-aged Brazilian cohort would result in a significant increase in the population eligible for statins. This is largely driven by males and older individuals. Additional cost-effectiveness analyses are needed to define the appropriateness of this strategy in the Brazilian population.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Proportion of individuals eligible for statins according to the Brazilian guideline and the two thresholds for the new 2013 ACC/AHA guideline. The values are in percent of the total population included in the study. Abbreviations: ACC/AHA, American College of Cardiology/American Heart Association; LDL, low‐density lipoprotein cholesterol.
Figure 2
Figure 2
Proportion of individuals eligible for statins according to the Brazilian guideline and the two thresholds for the new 2013 ACC/AHA guideline, stratified by age. Abbreviations: ACC/AHA, American College of Cardiology/American Heart Association.
Figure 3
Figure 3
Proportion of individuals eligible for statins according to the Brazilian guideline and the 2 thresholds for the new 2013 ACC/AHA guideline, stratified by (A) sex and (B) race. Abbreviations: ACC/AHA, American College of Cardiology/American Heart Association.
See this image and copyright information in PMC

References

    1. Sposito AC, Caramelli B, Fonseca FA, et al. IV Brazilian Guideline for Dyslipidemia and Atherosclerosis prevention: Department of Atherosclerosis of Brazilian Society of Cardiology [article in Portuguese]. Arq Bras Cardiol. 2007;88(suppl 1):2–19. - PubMed
    1. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults . Executive Summary of the Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:2486–2497. - PubMed
    1. Stone NJ, Robinson JG, Lichtenstein AH, et al; American College of Cardiology/American Heart Association Task Force on Practice Guidelines . 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines [published correction appears in Circulation. 2014;129(25 suppl 2):S46–S48]. Circulation. 2014;129(25 suppl 2):S1–S45. - PubMed
    1. Wenger NK. Prevention of cardiovascular disease: highlights for the clinician of the 2013 American College of Cardiology/American Heart Association guidelines. Clin Cardiol. 2014;37:239–251. - PMC - PubMed
    1. Cook NR, Ridker PM. Response to Comment on the reports of over‐estimation of ASCVD risk using the 2013 AHA/ACC risk equation. Circulation. 2014;129:268–269. - PubMed

MeSH terms

LinkOut - more resources